Ruvinov Emil, Dvir Tal, Leor Jonathan, Cohen Smadar
Department of Biotechnology Engineering, Ben-Gurion University of the Negev, Beer-Sheva 84105, Israel.
Expert Rev Cardiovasc Ther. 2008 Jun;6(5):669-86. doi: 10.1586/14779072.6.5.669.
Cardiac tissue reconstruction following myocardial infarction represents a major challenge in cardiovascular therapy, as current clinical approaches are limited in their ability to regenerate or replace damaged myocardium. Thus, different novel treatments have been introduced aimed at myocardial salvage and repair. Here, we present a review of recent advancements in cardiac cell, gene-based and tissue engineering therapies. Selected strategies in cell therapy and new tools for myocardial gene transfer are summarized. Finally, we consider novel approaches to myocardial tissue engineering as a platform for the integration of various modalities in an attempt to rejuvenate infarcted tissue in vivo.
心肌梗死后的心脏组织重建是心血管治疗中的一项重大挑战,因为目前的临床方法在再生或替代受损心肌的能力方面存在局限性。因此,已引入了不同的新型治疗方法,旨在挽救和修复心肌。在此,我们对心脏细胞、基因疗法和组织工程疗法的最新进展进行综述。总结了细胞治疗中的选定策略和心肌基因转移的新工具。最后,我们将心肌组织工程的新方法视为整合各种方式的平台,试图在体内使梗死组织恢复活力。